Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2004
11/17/2004EP1476176A2 Transport peptides and uses therefor
11/17/2004EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004EP1055125B1 Interaction between cyclin d1 and steroid receptor co-activators
11/17/2004EP0979245B1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/17/2004EP0907658B1 Neuropeptide y agonists
11/17/2004EP0897392B1 Peptides binding sh3 domain of cortactin and their use
11/17/2004EP0731811B1 Chaperonin 10
11/17/2004EP0731106B1 Dolastatin derivatives
11/17/2004CN1547608A Modified factor IX
11/17/2004CN1547480A Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivati
11/17/2004CN1546522A Alkaline fibroblast growth factor antigen epitope peptide and its screening method
11/16/2004US6818659 Targets and binds biological receptors; medical diagnosis; magnetic resonance, x-ray, ultrasound, and contrast imaging
11/16/2004US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004US6818619 Chimeric natriuretic peptides
11/16/2004US6818422 For preventing/treating human arteriosclerosis by inhibiting generation of foamy macrophage
11/16/2004US6818408 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
11/16/2004US6818217 Immunoreactive peptides
11/16/2004US6818201 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
11/11/2004WO2004097416A1 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for structure
11/11/2004WO2004097406A2 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION
11/11/2004WO2004096840A1 Template- fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
11/11/2004WO2004096839A1 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
11/11/2004WO2004096838A1 Template-fixed peptidomimetics as medicaments against hiv and cancer
11/11/2004WO2004096837A1 Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same
11/11/2004WO2004096291A1 In vivo imaging using peptide derivatives
11/11/2004WO2004069858A3 Leukocyte stimulating peptides
11/11/2004WO2004015070A3 Isolation and identification of t cells
11/11/2004WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists
11/11/2004WO2003046574A3 Complement c3 precursor biopolymer markers indicative of insulin resistance
11/11/2004WO2002096350A3 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
11/11/2004US20040224898 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening
11/11/2004US20040224896 STQ peptides
11/11/2004US20040224400 Novel multifunctional adhesin proteins and their display in microbial cells
11/11/2004US20040224385 Zinc finger binding domains for cnn
11/11/2004US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004CA2847490A1 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
11/11/2004CA2847486A1 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
11/11/2004CA2524253A1 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
11/10/2004EP1475442A2 Polypeptides of feline T-cell lymphotropic lentivirus
11/10/2004EP1474432A1 Immunostimulatory, covalently lipidated oligonucleotides
11/10/2004EP1474430A1 Bi-functionalised metallocenes use for marking biological molecules
11/10/2004EP1474120A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/10/2004EP0986754A4 Synthetic antibiotics
11/10/2004CN1544464A Peptides
11/10/2004CN1544461A Uro-genital condition treatment system
11/10/2004CN1174998C Peptide immunogens for prevention and treatment of allergy
11/10/2004CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof
11/09/2004US6815423 Fluorescent substance P
11/09/2004US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004CA2035381C Preparation and use of gene banks of human antibodies ("human-antibody libraries")
11/04/2004WO2004094471A2 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
11/04/2004WO2004094464A1 Oligopeptides, composition and use thereof as elicitors of the natural defences of plants
11/04/2004WO2004094461A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
11/04/2004WO2004094452A2 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
11/04/2004WO2004093807A2 Somatostatin vectors
11/04/2004WO2004093662A2 Method for detecting prognosis of cancer
11/04/2004WO2004064780A3 Peptide-based angiogenesis inhibitors and methods of use thereof
11/04/2004WO2004024173A3 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
11/04/2004WO2004020454A3 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
11/04/2004WO2004009540A3 Methods and kits for transferases
11/04/2004WO2003060091A3 Selective melanin-concentrating hormone type -1 receptor agonists
11/04/2004WO2003021226A3 Peptide biomarker and method of identification
11/04/2004WO2002086070A3 Binding molecules for fc-region polypeptides
11/04/2004US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004US20040220110 Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/04/2004US20040220108 Neo-tryptophan
11/04/2004US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004US20040220091 Process for preparation of cyclosporin A analogs
11/04/2004US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004US20040219575 Using presence of transcription factor/tumor antigen splice variant to diagnose cell proliferative disorders; tumor cell characterization
11/04/2004US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004CA2523197A1 Peptide vectors
11/04/2004CA2522758A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
11/04/2004CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/03/2004EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004EP1472337A1 Induction of tumor immunity by variants of folate binding protein
11/03/2004EP1472284A2 Fluorogenic protease substrates doubly labelled with rhodamine moieties
11/03/2004EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004EP1472276A2 Small peptides capable of modulating the function of cd66 (ceacam) family members
11/03/2004EP1471936A2 Hiv vaccine and method of use
11/03/2004EP1471929A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2004EP1471920A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
11/03/2004EP1395584A4 Uronium and immonium salts for peptide coupling
11/03/2004EP1206494B1 Computational design methods for making molecular mimetics
11/03/2004EP0789708B1 Multifunctional molecular complexes for gene transfer to cells
11/03/2004EP0698101B1 Hepatitis-c virus type 4, 5 and 6
11/03/2004CN1543471A Process for producing sugar chain asparagine derivative
11/03/2004CN1541706A Inhibitor and stimulator of stem cell proliferation and uses thereof
11/03/2004CN1174094C Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes
11/02/2004US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
11/02/2004CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
11/02/2004CA1341463C Cyclosporin a derivatives modified at position 1 and fluorescence polarization assay for cyclosporin a and metabolites
10/2004
10/28/2004WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004WO2004092205A1 Hydroxy-substituted-20-acyloxy-camptothecin polymer derivatives and use of the same for the manufacture of a medicament
10/28/2004WO2004092202A1 Process for production of cyclic peptides
10/28/2004WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004WO2004052922A3 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage
10/28/2004WO2004041151A3 Neuroprotective iron chelators and pharmaceutical compositions comprising them
10/28/2004WO2003087126A3 Heteroclitic analogs and related methods